Investors

Media Coverage

NASDAQ: ENVB

Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts

Media Coverage

Dr. Joe Tucker, CEO of Enveric Biosciences [The Green Rush]

February 29, 2024

12 Health Care Stocks Moving In Thursday’s Pre-Market Session [Benzinga]

February 29, 2024

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds [Benzinga]

February 29, 2024

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments [Benzinga]

February 23, 2024

Enveric sells cannabis patents to focus on psilocin candidates [Green Market Report]

February 23, 2024

Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds [Benzinga]

February 21, 2024

Non-Hallucinogenic Psilocybin-Based Therapies Promote Neuroplasticity Show Promise Treating Mental Health Disorders with Joe Tucker Enveric Biosciences [Empowered Patient Podcast]

February 12, 2024

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders [ACS Publications]

January 29, 2024

The trends that will shape the biotech industry in 2024 [Labiotech]

January 25, 2024

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond [Benzinga]

January 10, 2024

‹
1
…
3
4
5
6
7
…
12
›

Company

Team

Psybrary™

Pipeline

Investors

Contact

Sign Up for Updates

© 2025 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.